Cargando…
Serum HMGB1 is a biomarker for acute myocardial infarction with or without heart failure
This study measured serum high mobility group box 1 (HMGB1) levels in patients with acute myocardial infarction (AMI) and/or heart failure (HF) and evaluated their relationship with peripheral inflammatory biomarkers and cardiac biomarkers, which have not been reported before. Of the patients, 55 ha...
Autores principales: | Wahid, Abdul, Wen, Juan, Yang, Qiong, Zhang, Zhihui, Zhao, Xiexiong, Tang, Xiaohong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10651663/ https://www.ncbi.nlm.nih.gov/pubmed/37775976 http://dx.doi.org/10.1111/cts.13630 |
Ejemplares similares
-
The Biomarkers for Acute Myocardial Infarction and Heart Failure
por: Wang, Xi-Ying, et al.
Publicado: (2020) -
Sex differences in the association between blood pressure and atrial fibrillation: A case-control study
por: Zhao, Xiexiong, et al.
Publicado: (2022) -
Galectin-3 as a Prognostic Biomarker in Patients with First Acute Myocardial Infarction without Heart Failure
por: Vucic, Rada M., et al.
Publicado: (2023) -
lncRNA-NRF is a Potential Biomarker of Heart Failure After Acute Myocardial Infarction
por: Yan, Li, et al.
Publicado: (2020) -
Serum Aldosterone as Predictor of Progression of Coronary Heart Disease in Patients Without Signs of Heart Failure After Acute Myocardial Infarction
por: Resic, Nerma, et al.
Publicado: (2018)